Prognosis Clinical Trial
Official title:
Pilot Study of Personalized First-line Chemotherapy Choice for Patients With Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)
The aim of this study is to assess the clinical value of 5 transcriptomic signatures prognostic of chemotherapeutic sensitivity to improve the Objective Response Rate (ORR) of first-line (L1). Chemotherapy regimen (FOLFIRINOX vs Gem-nabP) will be selected based on transcriptomic signatures applied to the pre-therapeutic liver biopsy of newly diagnosed PDAC patients.
Step 1: patients will sign a 1st informed consent prospectively for the molecular screening (RNAseq profile). 5 transcriptomic signatures will be applied for prediction of response to 5 Fluoro-Uracil (5FU), oxaliplatin, irinotecan, gemcitabine and taxane. Biomarker status will be obtained for all patients as part of good clinical practice. Patients will be eligible for prospective step 2 only if the transcriptomic analysis is informative and the treatment can be started within 28 days. Step 2: study treatment strategy: based on the results of transcriptomic signatures, patients will receive either FOLFIRINOX or Gem-nabP according to the following algorithm (2nd informed consent): - Predicted to be FOLFIRINOX sensitive (regardless of sensitivity to Gem-nabP) = FOLFIRINOX - Predicted to be FOLFIRINOX and Gem-nabP resistant = FOLFIRINOX - Presence of a germline breast cancer (BRCA) mutation (regardless of transcriptomic signature) = FOLFIRINOX (tumors sensitive to platinum). - Predicted to be Gem-nabP sensitive and FOLFIRINOX resistant = Gem-nabP Chemotherapy with FOLFIRINOX and Gemcitabine plus nab-paclitaxel will be administered as in routine practice, according to their approval. Dose adaptation will be allowed according to investigator's usual practice. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101448 -
Prevalence of Bronchiectasis in COPD Patients
|
||
| Recruiting |
NCT03635619 -
The Application of 3T MRI in Esophageal Cancer
|
||
| Recruiting |
NCT04377854 -
Prognostic Value of BNP in MCS - a 25 Year Follow up Study
|
||
| Completed |
NCT05586828 -
A Single-center Retrospective Cohort Study to Explore the Prognostic Significance of CONUT in Elderly CAD Patients With HFpEFand Compare CONUT With Other Objective Nutritional Indices.
|
||
| Enrolling by invitation |
NCT04517981 -
Cohort Study on the Outcome and Influencing Factors of Perinatal Depression
|
||
| Recruiting |
NCT05229328 -
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
|
||
| Completed |
NCT04470440 -
Thyroid Dysfunction and Nivolumab Reponse in NSCLC
|
||
| Recruiting |
NCT05848310 -
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
|
||
| Completed |
NCT02582333 -
Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy
|
||
| Completed |
NCT03652402 -
Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN
|
||
| Recruiting |
NCT04651933 -
A Training Set for the HRD Model in EOC
|
||
| Completed |
NCT04651920 -
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
|
||
| Recruiting |
NCT03843905 -
Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma.
|
||
| Completed |
NCT05620537 -
A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients
|
||
| Recruiting |
NCT03738319 -
Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer
|
||
| Recruiting |
NCT03742869 -
HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma
|
||
| Completed |
NCT03268096 -
Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of Demyelination
|
||
| Recruiting |
NCT04004559 -
MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)
|
||
| Recruiting |
NCT05494502 -
Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT04411563 -
Epigenetic Tools as Prognostic Predictors in Covid19
|